Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations.
Journal Information
Full Title: Curr HIV/AIDS Rep
Abbreviation: Curr HIV/AIDS Rep
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Acquired Immunodeficiency Syndrome
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflicts of InterestThe authors declare no competing interests. Human and Animal RightsThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflicts of Interest The authors declare no competing interests."
"Funding This work was supported in part by AIDS Clinical Trials Group funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634 and UM1 AI068636, by Combined Immunologic Approaches to Cure HIV-1 funded under Award Number UM1 AI126603 and by the Statistical and Data Management Center of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network under the National Institute of Allergy and Infectious Diseases grant No. UM1 AI068616."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025